Sopharma Trading AD (XBUL:SFT) FFO


XBUL:SFT Sopharma Trading AD XBUL:SFT
82 GF Score
Price €2.90
GF Value €7.63
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sopharma Trading AD FFO?

FFO (Funds from operations) only applies to REITs.

XBUL:SFT
82GF Score
Sopharma Trading AD XBUL:SFT
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sopharma Trading AD (XBUL:SFT) Overvalued in 2026?

Based on GuruFocus' analysis, Sopharma Trading AD stock appears to be undervalued. The current stock price of €2.90 is trading 62% below its estimated GF Value™ of €7.63. GuruFocus considers Sopharma Trading AD to be Significantly Undervalued.

Key valuation signals for XBUL:SFT:

  • FFO:
  • GF Value™: €7.63 vs. price of €2.90 (62% below fair value)
  • GF Score™: 82/100 with 2 warning signs

No single metric tells the full story. See the XBUL:SFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sopharma Trading AD Business Description

Address Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.
82GF Score

Get the complete analysis for XBUL:SFT

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.90
Price
€7.63
GF Value